文献速递妇科

整合医疗系统中子宫肌瘤手术治疗后再次干预的长期风险

Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System.
PubMed 文献 · Obstet Gynecol · 2024-03-28

在Kaiser Permanente北加州整合医疗系统2009-2021年电子健康记录中,对10,324例18-50岁首次接受保留子宫手术的子宫肌瘤患者进行前瞻性队列随访,比较四种术式再次干预的长期风险。中位随访3.8年,7年再次干预风险:子宫肌瘤剔除术20.6%、子宫动脉栓塞术26.0%、子宫内膜消融术35.5%、宫腔镜子宫肌瘤剔除术37.0%;再次干预中63.2%为子宫切除术。

要点

  • 7年再次干预风险:子宫肌瘤剔除术20.6%,低于子宫动脉栓塞术26.0%、子宫内膜消融术35.5%、宫腔镜子宫肌瘤剔除术37.0%。
  • 再次干预中63.2%为子宫切除术。
  • 各术式内再次干预率不随BMI、种族和民族或邻里剥夺指数变化;子宫动脉栓塞术、子宫内膜消融术和宫腔镜子宫肌瘤剔除术后再次干预率随年龄降低,宫腔镜子宫肌瘤剔除术经产妇再次干预率高于未产者。

核心结论

  • 子宫动脉栓塞术、子宫内膜消融术和宫腔镜子宫肌瘤剔除术的长期再次干预风险高于子宫肌瘤剔除术,可能随患者年龄和产次变化,但不随BMI、种族和民族或邻里剥夺指数变化。

研究设计与样本

  • 前瞻性队列研究,纳入2009-2021年Kaiser Permanente北加州电子健康记录中10,324例18-50岁、确诊子宫肌瘤后首次接受保留子宫手术的患者。
  • 患者种族和民族构成:亚裔19.9%、黑人21.2%、西班牙裔21.3%、白人32.5%、其他种族和民族5.2%。
  • 首次手术类型:子宫肌瘤剔除术(开腹、腹腔镜或阴式)44.4%(4,587例)、子宫内膜消融术21.4%(2,211例)、宫腔镜子宫肌瘤剔除术18.0%(1,857例)、子宫动脉栓塞术16.2%(1,669例)。
  • 随访至再次干预(第二次保留子宫手术或子宫切除术)或删失,中位随访3.8年(四分位距1.8-7.4年)。
  • 采用Kaplan-Meier法计算再次干预累积发生率,Cox回归模型估计风险比和95%CI,调整年龄、产次、种族和民族、体重指数(BMI)、邻里剥夺指数和年份,并评估人口学特征的效应修饰。

主要发现

  • 考虑删失后,7年再次干预风险:子宫肌瘤剔除术20.6%、子宫动脉栓塞术26.0%、子宫内膜消融术35.5%、宫腔镜子宫肌瘤剔除术37.0%。
  • 再次干预中63.2%为子宫切除术。
  • 各术式内再次干预率不随BMI、种族和民族或邻里剥夺指数变化。
  • 子宫动脉栓塞术、子宫内膜消融术和宫腔镜子宫肌瘤剔除术后再次干预率随年龄降低。
  • 宫腔镜子宫肌瘤剔除术经产妇再次干预率高于未产者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare long-term risk of reintervention across four uterus-preserving surgical treatments for leiomyomas and to assess effect modification by sociodemographic factors in a prospective cohort study in an integrated health care delivery system. METHODS: We studied a cohort of 10,324 patients aged 18-50 (19.9% Asian, 21.2% Black, 21.3% Hispanic, 32.5% White, 5.2% additional races and ethnicities) who had a first uterus-preserving procedure (abdominal, laparoscopic, or vaginal myomectomy [referred to as myomectomy]; hysteroscopic myomectomy; endometrial ablation; uterine artery embolization) after leiomyoma diagnosis in the 2009-2021 electronic health records of Kaiser Permanente Northern California. We followed up patients until reintervention (second uterus-preserving procedure or hysterectomy) or censoring. We used a Kaplan-Meier estimator to calculate the cumulative incidence of reintervention and Cox regression models to estimate hazard ratios and 95% CIs comparing rates of reintervention across procedures, adjusting for age, parity, race and ethnicity, body mass index (BMI), Neighborhood Deprivation Index, and year. We also assessed effect modification by demographic characteristics. RESULTS: Median follow-up was 3.8 years (interquartile range 1.8-7.4 years). Index procedures were 18.0% (1,857) hysteroscopic myomectomies, 16.2% (1,669) uterine artery embolizations, 21.4% (2,211) endometrial ablations, and 44.4% (4,587) myomectomies. Accounting for censoring, the 7-year reintervention risk was 20.6% for myomectomy, 26.0% for uterine artery embolization, 35.5% for endometrial ablation, and 37.0% for hysteroscopic myomectomy; 63.2% of reinterventions were hysterectomies. Within each procedure type, reintervention rates did not vary by BMI, race and ethnicity, or Neighborhood Deprivation Index. However, rates of reintervention after uterine artery embolization, endometrial ablation, and hysteroscopic myomectomy decreased with age, and reintervention rates for hysteroscopic myomectomy were higher for parous than nulliparous patients. CONCLUSION: Long-term reintervention risks for uterine artery embolization, endometrial ablation, and hysteroscopic myomectomy are greater than for myomectomy, with potential variation by patient age and parity but not BMI, race and ethnicity, or Neighborhood Deprivation Index.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mitro SD, Xu F, Lee C, et al. Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System. Obstet Gynecol. 2024. PMID: 38547478. doi:10.1097/AOG.0000000000005557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。